To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04767906
Title Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors (CaPture)
Acronym CaPture
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Leipzig
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Technische Universität Dresden, Medizinische Fakultät Carl Gustav Carus Medizinische Klinik und Poliklinik I Dresden Saxonia 01307 Germany Details
MVZ Mitte/MVZ Delitzsch GmbH Leipzig Saxonia 04103 Germany Details
University Hospital Leipzig Leipzig Saxonia 04103 Germany Details
Charite Universitätsmedizin, Campus Virchow Klinikum, Klinik für Hepatologie/Gastroenterologie Berlin 13353 Germany Details
Universitätsklinikum Mannheim Mannheim 68167 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field